Cargando…

A Questionnaire-based Study of the Views of Schizophrenia Patients and Psychiatric Healthcare Professionals in Japan about the Side Effects of Clozapine

OBJECTIVE: It is well documented that clozapine treatment causes agranulocytosis, but it can also induce drowsiness, constipation, and hypersalivation; however, these symptoms are usually less severe. It has been reported that clozapine-treated patients with schizophrenia and psychiatric healthcare...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Ippei, Hanya, Manako, Uno, Junji, Amano, Yuhei, Fukai, Keiko, Fujita, Kiyoshi, Kamei, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977806/
https://www.ncbi.nlm.nih.gov/pubmed/27489383
http://dx.doi.org/10.9758/cpn.2016.14.3.286
_version_ 1782447104622329856
author Takeuchi, Ippei
Hanya, Manako
Uno, Junji
Amano, Yuhei
Fukai, Keiko
Fujita, Kiyoshi
Kamei, Hiroyuki
author_facet Takeuchi, Ippei
Hanya, Manako
Uno, Junji
Amano, Yuhei
Fukai, Keiko
Fujita, Kiyoshi
Kamei, Hiroyuki
author_sort Takeuchi, Ippei
collection PubMed
description OBJECTIVE: It is well documented that clozapine treatment causes agranulocytosis, but it can also induce drowsiness, constipation, and hypersalivation; however, these symptoms are usually less severe. It has been reported that clozapine-treated patients with schizophrenia and psychiatric healthcare professionals consider different side effects to be important. The aim of this study was to assess current practice related to the side effects of clozapine in clozapine-treated patients with schizophrenia and psychiatric healthcare professionals in Japan. METHODS: Data were collected from January 2014 to August 2015 in Okehazama Hospital, Kakamigahara Hospital, and Numazu Chuo Hospital. Clozapine-treated patients with schizophrenia and psychiatric healthcare professionals (psychiatrists and pharmacists) were enrolled in this study. RESULTS: Of the 106 patients and 120 psychiatric healthcare professionals screened, 100 patients and 104 healthcare professionals were included in this study. We asked the patients what side effects caused them trouble and we asked psychiatric healthcare professionals what side effects caused them concern. The patients and psychiatrists held similarly positive views regarding the efficacy of clozapine. The healthcare professionals were concerned about agranulocytosis (92.4%), blood routines (61.3%). On the other hand, the patients experienced hypersalivation (76.0%), sleepiness (51.0%). A positive correlation (R=0.696) was found between patient satisfaction and DAI-10 score. CONCLUSION: Patients experienced more problems than healthcare professionals expected. However, usage experience of clozapine healthcare professionals tended to have similar results to patients. It is necessary that all healthcare professionals fully understand the efficacy and potential side effects of clozapine. This is very important for promoting clozapine treatment in Japan.
format Online
Article
Text
id pubmed-4977806
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Korean College of Neuropsychopharmacology
record_format MEDLINE/PubMed
spelling pubmed-49778062016-08-09 A Questionnaire-based Study of the Views of Schizophrenia Patients and Psychiatric Healthcare Professionals in Japan about the Side Effects of Clozapine Takeuchi, Ippei Hanya, Manako Uno, Junji Amano, Yuhei Fukai, Keiko Fujita, Kiyoshi Kamei, Hiroyuki Clin Psychopharmacol Neurosci Original Article OBJECTIVE: It is well documented that clozapine treatment causes agranulocytosis, but it can also induce drowsiness, constipation, and hypersalivation; however, these symptoms are usually less severe. It has been reported that clozapine-treated patients with schizophrenia and psychiatric healthcare professionals consider different side effects to be important. The aim of this study was to assess current practice related to the side effects of clozapine in clozapine-treated patients with schizophrenia and psychiatric healthcare professionals in Japan. METHODS: Data were collected from January 2014 to August 2015 in Okehazama Hospital, Kakamigahara Hospital, and Numazu Chuo Hospital. Clozapine-treated patients with schizophrenia and psychiatric healthcare professionals (psychiatrists and pharmacists) were enrolled in this study. RESULTS: Of the 106 patients and 120 psychiatric healthcare professionals screened, 100 patients and 104 healthcare professionals were included in this study. We asked the patients what side effects caused them trouble and we asked psychiatric healthcare professionals what side effects caused them concern. The patients and psychiatrists held similarly positive views regarding the efficacy of clozapine. The healthcare professionals were concerned about agranulocytosis (92.4%), blood routines (61.3%). On the other hand, the patients experienced hypersalivation (76.0%), sleepiness (51.0%). A positive correlation (R=0.696) was found between patient satisfaction and DAI-10 score. CONCLUSION: Patients experienced more problems than healthcare professionals expected. However, usage experience of clozapine healthcare professionals tended to have similar results to patients. It is necessary that all healthcare professionals fully understand the efficacy and potential side effects of clozapine. This is very important for promoting clozapine treatment in Japan. Korean College of Neuropsychopharmacology 2016-08 2016-08-31 /pmc/articles/PMC4977806/ /pubmed/27489383 http://dx.doi.org/10.9758/cpn.2016.14.3.286 Text en Copyright © 2016, Korean College of Neuropsychopharmacology This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Takeuchi, Ippei
Hanya, Manako
Uno, Junji
Amano, Yuhei
Fukai, Keiko
Fujita, Kiyoshi
Kamei, Hiroyuki
A Questionnaire-based Study of the Views of Schizophrenia Patients and Psychiatric Healthcare Professionals in Japan about the Side Effects of Clozapine
title A Questionnaire-based Study of the Views of Schizophrenia Patients and Psychiatric Healthcare Professionals in Japan about the Side Effects of Clozapine
title_full A Questionnaire-based Study of the Views of Schizophrenia Patients and Psychiatric Healthcare Professionals in Japan about the Side Effects of Clozapine
title_fullStr A Questionnaire-based Study of the Views of Schizophrenia Patients and Psychiatric Healthcare Professionals in Japan about the Side Effects of Clozapine
title_full_unstemmed A Questionnaire-based Study of the Views of Schizophrenia Patients and Psychiatric Healthcare Professionals in Japan about the Side Effects of Clozapine
title_short A Questionnaire-based Study of the Views of Schizophrenia Patients and Psychiatric Healthcare Professionals in Japan about the Side Effects of Clozapine
title_sort questionnaire-based study of the views of schizophrenia patients and psychiatric healthcare professionals in japan about the side effects of clozapine
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977806/
https://www.ncbi.nlm.nih.gov/pubmed/27489383
http://dx.doi.org/10.9758/cpn.2016.14.3.286
work_keys_str_mv AT takeuchiippei aquestionnairebasedstudyoftheviewsofschizophreniapatientsandpsychiatrichealthcareprofessionalsinjapanaboutthesideeffectsofclozapine
AT hanyamanako aquestionnairebasedstudyoftheviewsofschizophreniapatientsandpsychiatrichealthcareprofessionalsinjapanaboutthesideeffectsofclozapine
AT unojunji aquestionnairebasedstudyoftheviewsofschizophreniapatientsandpsychiatrichealthcareprofessionalsinjapanaboutthesideeffectsofclozapine
AT amanoyuhei aquestionnairebasedstudyoftheviewsofschizophreniapatientsandpsychiatrichealthcareprofessionalsinjapanaboutthesideeffectsofclozapine
AT fukaikeiko aquestionnairebasedstudyoftheviewsofschizophreniapatientsandpsychiatrichealthcareprofessionalsinjapanaboutthesideeffectsofclozapine
AT fujitakiyoshi aquestionnairebasedstudyoftheviewsofschizophreniapatientsandpsychiatrichealthcareprofessionalsinjapanaboutthesideeffectsofclozapine
AT kameihiroyuki aquestionnairebasedstudyoftheviewsofschizophreniapatientsandpsychiatrichealthcareprofessionalsinjapanaboutthesideeffectsofclozapine
AT takeuchiippei questionnairebasedstudyoftheviewsofschizophreniapatientsandpsychiatrichealthcareprofessionalsinjapanaboutthesideeffectsofclozapine
AT hanyamanako questionnairebasedstudyoftheviewsofschizophreniapatientsandpsychiatrichealthcareprofessionalsinjapanaboutthesideeffectsofclozapine
AT unojunji questionnairebasedstudyoftheviewsofschizophreniapatientsandpsychiatrichealthcareprofessionalsinjapanaboutthesideeffectsofclozapine
AT amanoyuhei questionnairebasedstudyoftheviewsofschizophreniapatientsandpsychiatrichealthcareprofessionalsinjapanaboutthesideeffectsofclozapine
AT fukaikeiko questionnairebasedstudyoftheviewsofschizophreniapatientsandpsychiatrichealthcareprofessionalsinjapanaboutthesideeffectsofclozapine
AT fujitakiyoshi questionnairebasedstudyoftheviewsofschizophreniapatientsandpsychiatrichealthcareprofessionalsinjapanaboutthesideeffectsofclozapine
AT kameihiroyuki questionnairebasedstudyoftheviewsofschizophreniapatientsandpsychiatrichealthcareprofessionalsinjapanaboutthesideeffectsofclozapine